Aurora Cannabis Inc (NYSE:ACB) Receives $8.46 Consensus Target Price from Analysts

Shares of Aurora Cannabis Inc (NYSE:ACB) have been given an average recommendation of “Hold” by the twelve research firms that are currently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $8.46.

ACB has been the subject of a number of recent research reports. Stifel Nicolaus initiated coverage on shares of Aurora Cannabis in a research note on Wednesday, June 5th. They issued a “hold” rating for the company. Compass Point initiated coverage on shares of Aurora Cannabis in a research note on Monday, July 8th. They issued a “neutral” rating for the company. Desjardins initiated coverage on shares of Aurora Cannabis in a research note on Thursday, April 25th. They issued a “buy” rating and a $9.07 price objective for the company. ValuEngine lowered shares of Aurora Cannabis from a “buy” rating to a “hold” rating in a research note on Friday, August 2nd. Finally, Zacks Investment Research upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research note on Tuesday, July 30th.

A number of large investors have recently made changes to their positions in the business. Actinver Wealth Management Inc. boosted its holdings in Aurora Cannabis by 6.4% in the 1st quarter. Actinver Wealth Management Inc. now owns 20,090 shares of the company’s stock valued at $182,000 after purchasing an additional 1,215 shares during the period. Glassman Wealth Services boosted its holdings in Aurora Cannabis by 8.2% in the 1st quarter. Glassman Wealth Services now owns 17,587 shares of the company’s stock valued at $159,000 after purchasing an additional 1,326 shares during the period. Moloney Securities Asset Management LLC boosted its holdings in Aurora Cannabis by 13.9% in the 1st quarter. Moloney Securities Asset Management LLC now owns 12,320 shares of the company’s stock valued at $112,000 after purchasing an additional 1,500 shares during the period. Truvestments Capital LLC boosted its holdings in Aurora Cannabis by 3.3% in the 2nd quarter. Truvestments Capital LLC now owns 46,344 shares of the company’s stock valued at $362,000 after purchasing an additional 1,500 shares during the period. Finally, Focused Wealth Management Inc boosted its holdings in Aurora Cannabis by 33.6% in the 1st quarter. Focused Wealth Management Inc now owns 6,574 shares of the company’s stock valued at $60,000 after purchasing an additional 1,654 shares during the period. 9.04% of the stock is owned by hedge funds and other institutional investors.

Aurora Cannabis stock traded down $0.21 during mid-day trading on Friday, reaching $6.62. The company’s stock had a trading volume of 11,998,441 shares, compared to its average volume of 21,436,111. Aurora Cannabis has a 12-month low of $4.05 and a 12-month high of $12.52. The firm has a market cap of $6.70 billion, a P/E ratio of 55.17 and a beta of 2.44. The company has a quick ratio of 1.98, a current ratio of 2.37 and a debt-to-equity ratio of 0.10. The stock has a fifty day moving average of $7.05.

Aurora Cannabis (NYSE:ACB) last released its quarterly earnings data on Tuesday, May 14th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.05). Aurora Cannabis had a negative net margin of 122.65% and a positive return on equity of 1.24%. The business had revenue of $49.00 million during the quarter, compared to analysts’ expectations of $50.92 million. Equities analysts expect that Aurora Cannabis will post -0.23 EPS for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

See Also: Intrinsic Value and Stock Selection

Analyst Recommendations for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit